![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 38/37 | (2006.01) |
(11) | Number of the document | 2968477 |
(13) | Kind of document | T |
(96) | European patent application number | 14725816.4 |
Date of filing the European patent application | 2014-03-14 | |
(97) | Date of publication of the European application | 2016-01-20 |
(45) | Date of publication and mention of the grant of the patent | 2019-12-04 |
(46) | Date of publication of the claims translation | 2020-03-10 |
(86) | Number | PCT/US2014/029354 |
Date | 2014-03-14 |
(87) | Number | WO 2014/144795 |
Date | 2014-09-18 |
(30) | Number | Date | Country code |
201361800293 P | 2013-03-15 | US | |
201361817085 P | 2013-04-29 | US | |
201361829884 P | 2013-05-31 | US | |
201361839477 P | 2013-06-26 | US | |
201361863860 P | 2013-08-08 | US | |
201361876927 P | 2013-09-12 | US | |
201361879955 P | 2013-09-19 | US | |
201361897742 P | 2013-10-30 | US |
(72) |
MALONEY, Kevin, US
ABDUL-FATTAH, Ahmad, US
GAGE, Daniel, US
|
(73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham, MA 02451,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Faktoriaus VIII polipeptido kompozicijos |
FACTOR VIII POLYPEPTIDE FORMULATIONS |
Payment date | Validity (years) | Amount | |
2025-01-21 | 12 | 289.00 EUR |
2026-03-14 |